Drugmaker set to profit from unsafe opioid

It's not uncommon for drug companies to try to keep generic versions of their best-selling drugs off the market. But this is a story about a drug company that went to extraordinary lengths to do so, calling into question the safety of a drug it had sold for years. When its plan didn't work, the company made an unusual decision.

Comments

Post a Comment

Popular posts from this blog

Canadian transit agency teases amazing new transportation technology: the bus

Image
Last week, one of Toronto’s regional public transit services teased a radical, futuristic mode of transportation on Twitter. In a dramatic video full of lightning strikes and movie trailer music, GO Transit asked viewers to imagine this scenario: you hop in a vehicle, slide into a comfortable seat, and text or browse cat memes until you arrive at your destination. Best of all, you never even need to input where you’re going. The vehicle just gets you there . And then pow! Another lightning strike! Surprise! It’s a bus! It’s like the self-driving car is already here. Read, sleep, watch and text. Experience. The Bus. From GO. The GO Bus. #GOxAutoShow pic.twitter.com/AjKylnfBzo — GO Transit (@GOtransit) February 14, 2019 The cheeky video makes a decent point. Mass transit already offers some of the benefits we’re trying to wring out of not-quite-here-yet technologies like self-driving cars. Yes, there are problems with even the best mass transit systems, like poor infrastruc
Read more